Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease

被引:4
作者
Zailaie, Samar A. [1 ]
Khoja, Basmah B. [1 ]
Siddiqui, Jumana J. [2 ]
Mawardi, Mohammad H. [3 ]
Heaphy, Emily [1 ]
Aljagthmi, Amjad [1 ]
Sergi, Consolato M. [4 ,5 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr Jeddah KFSHR, Res Ctr, Jeddah 21499, Saudi Arabia
[2] King Abdulaziz Univ, Fac Sci, Biochem Dept, Jeddah 21589, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr Jeddah KFSHR, Med Dept, Gastroenterol Sect, Jeddah 21499, Saudi Arabia
[4] Univ Ottawa, Childrens Hosp Eastern Ontario CHEO, Ottawa, ON K1H 8L1, Canada
[5] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2R3, Canada
关键词
ncRNA; miRNA; PiwiRNA; LncRNA; CircRNA; NAFLD; NASH; oxidative stress; metabolic dysfunction; insulin resistance; HEPATIC STELLATE CELLS; PIWI-INTERACTING RNA; FIBROSIS; STEATOHEPATITIS; METABOLISM; PROGRESSION; ACTIVATION; PATHWAY; GLUCOSE; OBESITY;
D O I
10.3390/ncrna10010010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-coding RNAs (ncRNAs) are RNA molecules that do not code for protein but play key roles in regulating cellular processes. NcRNAs globally affect gene expression in diverse physiological and pathological contexts. Functionally important ncRNAs act in chromatin modifications, in mRNA stabilization and translation, and in regulation of various signaling pathways. Non-alcoholic fatty liver disease (NAFLD) is a set of conditions caused by the accumulation of triacylglycerol in the liver. Studies of ncRNA in NAFLD are limited but have demonstrated that ncRNAs play a critical role in the pathogenesis of NAFLD. In this review, we summarize NAFLD's pathogenesis and clinical features, discuss current treatment options, and review the involvement of ncRNAs as regulatory molecules in NAFLD and its progression to non-alcoholic steatohepatitis (NASH). In addition, we highlight signaling pathways dysregulated in NAFLD and review their crosstalk with ncRNAs. Having a thorough understanding of the disease process's molecular mechanisms will facilitate development of highly effective diagnostic and therapeutic treatments. Such insights can also inform preventive strategies to minimize the disease's future development.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Expanding Pharmacists' Role in the Management of Non-Alcoholic Fatty Liver Disease
    Syed-Abdul, Majid Mufaqam
    PHARMACY, 2023, 11 (05)
  • [32] Systematic Analysis of Long Non-Coding RNA Genes in Nonalcoholic Fatty Liver Disease
    Ilieva, Mirolyuba
    Dao, James
    Miller, Henry E.
    Madsen, Jens Hedelund
    Bishop, Alexander J. R.
    Kauppinen, Sakari
    Uchida, Shizuka
    NON-CODING RNA, 2022, 8 (04)
  • [33] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Rockstroh, Juergen Kurt
    CURRENT HIV/AIDS REPORTS, 2017, 14 (02) : 47 - 53
  • [34] Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria
    Schwenger, Katherine J. P.
    Bolzon, Colin M.
    Li, Carrie
    Allard, Johane P.
    EUROPEAN JOURNAL OF NUTRITION, 2019, 58 (05) : 1771 - 1784
  • [35] Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
    Valenzuela-Vallejo, Laura
    Sanoudou, Despina
    Mantzoros, Christos S.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [36] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [37] Phenotyping the effect of diet on non-alcoholic fatty liver disease
    de Wit, Nicole J. W.
    Afman, Lydia A.
    Mensink, Marco
    Muller, Michael
    JOURNAL OF HEPATOLOGY, 2012, 57 (06) : 1370 - 1373
  • [38] A role of peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease
    Skat-Rordam, Josephine
    Ipsen, David Hojland
    Lykkesfeldt, Jens
    Tveden-Nyborg, Pernille
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 124 (05) : 528 - 537
  • [39] The Role of Epigenetics in the Progression of Non-Alcoholic Fatty Liver Disease
    Edith Aguilar-Olivos, Nancy
    Oria-Hernandez, Jesus
    Ponciano-Rodriguez, Guadalupe
    Carlos Chavez-Tapia, Norberto
    Uribe, Misael
    Mendez-Sanchez, Nahum
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2015, 15 (14) : 1187 - 1194
  • [40] Non-Coding RNAs Involved in the Regulation of Signaling Pathways as Possible Markers of Non-Alcoholic Fatty Liver Disease Progression
    Topchieva, L. V.
    Kurbatova, I. V.
    Dudanova, O. P.
    Vasilyeva, A. V.
    Zhulay, G. A.
    BIOLOGY BULLETIN, 2024, 51 (05) : 1271 - 1290